Revapharma Llp - Company Profile

Q: Who are the current directors of Revapharma Llp?

The current directors of Revapharma Llp are Shishant Gupta, Gurpreet Sandhu Singh.

It is a pharma limited liability partnership based in New Delhi, Delhi, India, established in 2020.

2020 New Delhi, Delhi, India Active

Last Updated: March 06, 2026

About Revapharma Llp

Revapharma Llp, a active limited liability partnership, was established on 17 February 2020 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAR-9430. Registered under ROC Roc Delhi I. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Shishant Gupta (Designated Partner), Gurpreet Sandhu Singh (Designated Partner). Past directors included Nizar Balan. It holds ₹5.00 M open charges and no settled loans. Its latest date of accounts and solvency statement 31 March 2024. It is based at A-4, Part A, Mahipalpur Extended Abadi Of Village Mahipalpur,, Main Vasant Kunj Road, Opp. To Jagannath Complex, New Delhi, Delhi, 110037.

Company Details

CIN/LLPIN
AAR-9430
Incorporation Date
17 February 2020
Total Obligation of Contribution
₹0.10 M
ROC Code
Roc Delhi I
Company Status
Active

Key Metrics

Obligation of Contribution ₹ 0.10 M as on 06-03-2026
Company Age 6 Year, 2 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 5.00 M as on 06-03-2026

Comprehensive Company Insights

Explore comprehensive insights into Revapharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Revapharma Llp?

Current Designated Partners

Name	Designation	Appointment Date	Status
Shishant Gupta	Designated Partner	04 Jun 2022	Current
Gurpreet Sandhu Singh	Designated Partner	17 Feb 2020	Current

Past Designated Partners

Name	Designation	Cessation	Status
Pramod Abcsdd	Designated Partner	04 Jun 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Revapharma Llp.

Enhance accessibility to Revapharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Revapharma Llp?

Unlock access to Revapharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹5,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Daimler Financial Services India Private Limited : 0.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
26 Feb 2021	Daimler Financial Services India Private Limited	₹5.00 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Revapharma Llp?

Unlock and access historical data on people associated with Revapharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Revapharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revapharma Llp's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Revapharma Llp

Recent Activity within the Organization

Annual General Meeting

Revapharma Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was recorded as a recent event.
31 Mar 2024
Statement of Assets & Liabilities

Progress on Revapharma Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi I. was documented.
31 Mar 2024
Director Appointment

The activity Shishant Gupta was appointed as a Designated Partner was appointed as a Designated Partner on 04 Jun 2022 & has been associated with this company since 3 years 11 months . was completed.
04 Jun 2022
Charges

The activity A charge with Daimler Financial Services India Private Limited amounted to Rs. 5.00 M with Charge ID 100438533 was registered on 26 Feb 2021. was completed.
26 Feb 2021
Director Appointment

Gurpreet Sandhu Singh was appointed as a Designated Partner was appointed as a Designated Partner on 17 Feb 2020 & has been associated with this company since 6 years 2 months . was recorded as a recent event.
17 Feb 2020
LLP Incorporation

Revapharma Llp was registered on 17 Feb 2020 with Roc Delhi I & aged 6 years 2 months as per MCA records. was recorded as a recent event.
17 Feb 2020

Explore recent activity and updates - View Recent Activity